Julia W. Mason’s scientific contributions

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (5)


The Myth of “Reliable Research” in Pediatric Gender Medicine: A critical evaluation of the Dutch Studies—and research that has followed
  • Article

January 2023

·

257 Reads

·

34 Citations

E. Abbruzzese

·

·

Julia W. Mason

Two Dutch studies formed the foundation and the best available evidence for the practice of youth medical gender transition. We demonstrate that this work is methodologically flawed and should have never been used in medical settings as justification to scale this "innovative clinical practice." Three methodological biases undermine the research: (1) subject selection assured that only the most successful cases were included in the results; (2) the finding that "resolution of gender dysphoria" was due to the reversal of the questionnaire employed; (3) concomitant psychotherapy made it impossible to separate the effects of this intervention from those of hormones and surgery. We discuss the significant risk of harm that the Dutch research exposed, as well as the lack of applicability of the Dutch protocol to the currently escalating incidence of adolescent-onset, non-binary, psychiatrically challenged youth, who are preponderantly natal females. "Spin" problems-the tendency to present weak or negative results as certain and positive-continue to plague reports that originate from clinics that are actively administering hormonal and surgical interventions to youth. It is time for gender medicine to pay attention to the published objective systematic reviews and to the outcome uncertainties and definable potential harms to these vulnerable youth.



Commentary: The Signal and the Noise—questioning the benefits of puberty blockers for youth with gender dysphoria—a commentary on Rew et al. (2021)
  • Article
  • Full-text available

December 2021

·

261 Reads

·

16 Citations

·

William J. Malone

·

Patrick Clarke

·

[...]

·

This commentary is a critique of a recent systematic review of the evidence for the use of puberty blockers for youth with gender dysphoria (GD) by Rew et al. (2021). In our view, the review suffers from several methodological oversights including the omission of relevant studies and suboptimal analysis of the quality of the included studies. This has resulted in an incomplete and incorrect assessment of the evidence base for the use of puberty blockers. We find that Rew et al.’s conclusions and clinician recommendations are problematic, especially when discussing suicidality. A key message of the review’s abstract appears to be that puberty blockers administered in childhood reduce adult suicidality. However, the study used for the basis of this conclusion (Turban et al., 2020) did not make a causal claim between puberty blockers and decreased adult suicidality. Rather, it reported a negative association between using puberty blockers and lifetime suicidal ideation. The study design did not allow for determination of causation. Our commentary concludes by demonstrating how the GD medical literature, as it moves from one publication to the next, can overstate the evidence underpinning clinical practice recommendations for youth with GD.

Download


Citations (5)


... The current controversial debate among clinicians and researchers about gender dysphoria (GD) in adolescence is based on observations that raise many questions: Worldwide, specialized centers are showing increasing rates of youth, with a presentation of predominantly birth-assigned female adolescents who identify as boys/transmasculine and often wish for gender-affirming medical interventions (Aitken et al., 2015;Chen et al., 2016;de Graaf et al., 2018de Graaf et al., , 2021Herrmann et al., 2022;Kaltiala-Heino et al., 2015;Levitan et al., 2019), or who identify as nonbinary, beyond the established gender dualism of male or female (Chew et al., 2020;Herrmann et al., 2023a, b). Similarly, there have been reports of clinical subgroups of adolescents who, after gender-conforming development in childhood, first present with GD in adolescence (Hutchinson et al., 2020;Zucker, 2019), raising questions about whether these clusters may be different from earlier cases (often with prepubertal onset of GD), for example, regarding their levels of psychological problems (Abbruzzese et al., 2023). ...

Reference:

Onset Age and Internalizing Problems in Adolescents with Gender Dysphoria: Is There an Association?
The Myth of “Reliable Research” in Pediatric Gender Medicine: A critical evaluation of the Dutch Studies—and research that has followed
  • Citing Article
  • January 2023

... The significant rate of problematic adaptations, psychiatric symptoms, and self-harm in this youth cohort […] is explained away as merely manifestations of minority stress, with unsubstantiated claims that these mental health problems will resolve with gender transition-and only with gender transition ( [84] p115). ...

What Are We Doing to These Children? Response to Drescher, Clayton, and Balon Commentaries on Levine et al., 2022
  • Citing Article
  • October 2022

... their findings were consistent with later systematic evidence reviews: low-quality evidence for physical effects of hormonal interventions; evidence regarding psychosocial and cognitive impact was "generally lacking." rew et al. (2021) has been extensively criticized for an inadequate search strategy, inappropriate attribution of causation, failure to adequately assess certainty of evidence, and absence of appropriate process for making recommendations (Clayton et al., 2022). ramos et al. (2021) noted studies were at risk of bias, and did not assess evidence certainty. ...

Commentary: The Signal and the Noise—questioning the benefits of puberty blockers for youth with gender dysphoria—a commentary on Rew et al. (2021)

... These limitations to accessing GAMT are increasingly paralleled in Europe. For example, in Sweden, pediatric endocrinologists now only prescribe puberty suppression under strict conditions [15]. Similarly, NHS England recently made the decision to reorganize the provision of GAMT for TGD youth and restrict the prescription of puberty suppression, further highlighting the precarity of this medical treatment [16][17][18]. ...

Puberty blockers for gender dysphoria: the science is far from settled
  • Citing Article
  • September 2021

The Lancet Child & Adolescent Health

... Psychosocial functioning is a core facet of human life that shapes how people relate to others and the quality of their social relationships. Psychosocial functioning refers to a variety of traits, characteristics and dispositions that have been broadly classified 14 as guidelines for gender-affirming hormone therapies as a reason to limit their use 41,42 . Therefore, a systematic review of changes in psychosocial functioning is useful to highlight outcomes for which there is strong evidence as well as to instigate further research on outcomes that need clarification. ...

Letter to the Editor from William J. Malone: “Proper Care of Transgender and Gender Diverse Persons in the Setting of Proposed Discrimination: A Policy Perspective”

The Journal of Clinical Endocrinology and Metabolism